CC
GILD icon

ClearArc Capital’s Gilead Sciences GILD Stock Holding History

ClearArc Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$767K Sell
11,803
-5,500
-32% -$358K 0.3% 81
2019
Q3 		$1.1M Buy
17,303
+35
+0.2% +$2.29K 0.32% 74
2019
Q2 		$1.17M Sell
17,268
-2,355
-12% -$155K 0.34% 68
2019
Q1 		$1.28M Sell
19,623
-894
-4% -$59.4K 0.34% 67
2018
Q4 		$1.28M Sell
20,517
-9,412
-31% -$658K 0.38% 64
2018
Q3 		$2.31M Buy
29,929
+186
+0.6% +$14K 0.3% 83
2018
Q2 		$2.11M Sell
29,743
-115
-0.4% -$8.12K 0.3% 84
2018
Q1 		$2.25M Sell
29,858
-3,397
-10% -$270K 0.34% 73
2017
Q4 		$2.38M Sell
33,255
-31,698
-49% -$2.41M 0.32% 74
2017
Q3 		$5.26M Buy
64,953
+32,908
+103% +$2.52M 0.79% 31
2017
Q2 		$2.27M Buy
32,045
+75
+0.2% +$4.99K 0.37% 66
2017
Q1 		$2.17M Sell
31,970
-56
-0.2% -$3.94K 0.36% 69
2016
Q4 		$2.29M Sell
32,026
-306
-0.9% -$22.7K 0.41% 64
2016
Q3 		$2.56M Sell
32,332
-37
-0.1% -$3.01K 0.48% 54
2016
Q2 		$2.7M Sell
32,369
-972
-3% -$86.3K 0.52% 53
2016
Q1 		$3.06M Sell
33,341
-1,922
-5% -$173K 0.65% 38
2015
Q4 		$3.57M Sell
35,263
-373
-1% -$38.8K 0.75% 27
2015
Q3 		$3.5M Sell
35,636
-742
-2% -$82.4K 0.73% 30
2015
Q2 		$4.26M Buy
36,378
+4,104
+13% +$448K 0.78% 24
2015
Q1 		$3.17M Buy
32,274
+107
+0.3% +$10.9K 0.65% 32
2014
Q4 		$3.03M Buy
32,167
+642
+2% +$66.4K 0.62% 33
2014
Q3 		$3.36M Buy
31,525
+178
+0.6% +$17.4K 0.76% 23
2014
Q2 		$2.6M Sell
31,347
-410
-1% -$31.9K 0.6% 38
2014
Q1 		$2.25M Buy
31,757
+1,621
+5% +$127K 0.56% 45
2013
Q4 		$2.26M Sell
30,136
-595
-2% -$41.4K 0.59% 41
2013
Q3 		$1.93M Sell
30,731
-6,330
-17% -$378K 0.54% 50
2013
Q2 		$1.9M Buy
+37,061
New +$1.93M 0.51% 52

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ClearArc Capital's GILD Position: Q4 2019 in Review

ClearArc Capital reduced its Gilead Sciences (GILD) stake by 32% in Q4 2019, selling an estimated $358K and leaving 11,803 shares worth $767K. The position accounts for 0.3% of the portfolio, ranked #81.

ClearArc Capital first reported a position in GILD in Q2 2013 and has held it in 27 quarters since. The position peaked at $5.26M in Q3 2017. 1,556 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • ClearArc Capital held 11,803 shares of Gilead Sciences worth $767K as of Q4 2019.
  • ClearArc Capital sold 5,500 Gilead Sciences shares in Q4 2019, an estimated $358K.
  • Gilead Sciences made up 0.3% of ClearArc Capital's portfolio in Q4 2019, its #81 holding.
  • ClearArc Capital first reported a position in Gilead Sciences in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Gilead Sciences position peaked at $5.26M in Q3 2017.
  • 1,556 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.